Trials / Completed
CompletedNCT01689038
Brain Imaging Study of F17464
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | F17464 | Single dose |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-09-20
- Last updated
- 2013-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01689038. Inclusion in this directory is not an endorsement.